About 1 in 31 children in the United States has been identified with autism spectrum disorder, according to the CDC’s most recent surveillance data from 2022. That translates to 3.2% of all 8-year-olds, making autism one of the most common developmental conditions in the country. The rate has risen steadily for more than two decades, though the increase is driven largely by better detection rather than a true surge in cases.
The Current Rate and How It’s Measured
The CDC tracks autism prevalence through its Autism and Developmental Disabilities Monitoring (ADDM) Network, which collects data from 16 sites across the country. The network focuses on 8-year-olds because that age captures most children who will eventually receive a diagnosis. The latest report, published in 2025, looked at children born in 2014 and found a prevalence of 32.2 per 1,000, or 1 in 31.
For younger children born in 2018 (aged 4 during the surveillance year), the network also tracks early identification rates. Comparing the two age groups helps researchers understand whether diagnoses are happening sooner, which matters because earlier intervention generally leads to better outcomes.
How the Rate Has Climbed Over Time
Two decades ago, autism was considered relatively rare. The CDC’s earliest ADDM estimates, based on children born in the mid-1990s, put the rate around 1 in 150. Since then, the numbers have moved in one direction:
- 2000 (birth year ~1992): approximately 1 in 150
- 2008 (birth year ~2000): approximately 1 in 88
- 2018 (birth year ~2010): approximately 1 in 44
- 2020 (birth year ~2012): approximately 1 in 36
- 2022 (birth year ~2014): 1 in 31
That trajectory looks alarming at first glance, but researchers at Johns Hopkins Bloomberg School of Public Health describe the pattern as “a gradual rise over the past 20 years due to broadened diagnostic definitions, better screening, and increased awareness” rather than an epidemic.
Why the Numbers Keep Rising
Two main factors explain most of the increase. First, the definition of autism itself has expanded. Conditions that once had their own separate diagnoses, like Asperger’s syndrome and pervasive developmental disorder, now fall under the single autism spectrum disorder umbrella. More people meet the current definition than would have met the narrower ones used in the 1990s.
Second, screening has become routine. Pediatricians now check for signs of autism at 18- and 24-month wellness visits, catching children who might have gone unidentified a generation ago. Parents and caregivers are also more familiar with early signs, and the stigma around seeking an evaluation has decreased. As Johns Hopkins researchers put it, “People are not as afraid to seek help and know where to go when they have concerns.”
None of this rules out the possibility that some portion of the increase reflects a genuine rise in autism. But the evidence points to detection as the primary driver.
Wide Variation Across States
The national figure of 1 in 31 masks enormous regional differences. Among the 16 ADDM sites, prevalence ranged from 1 in 103 in Laredo, Texas (1.0%) to 1 in 19 in California (5.3%). That fivefold gap has less to do with something in the water and more to do with how actively each community screens, evaluates, and documents autism.
California’s high rate, for example, reflects deliberate investment in early detection. The state’s “Get SET Early” program has trained hundreds of pediatricians to screen and refer children as young as possible, and regional centers across the state provide evaluations and service coordination for families. Pennsylvania, which had the second-highest identification rate, offers Medicaid to children with developmental disabilities regardless of family income, removing a financial barrier to diagnosis.
On the other end, communities with fewer diagnostic resources or less systematic screening tend to report lower rates. Across the ADDM Network, 66.5% of children identified with autism had a documented evaluation on file, but that ranged from just 24.7% in New Jersey to 93.5% in Puerto Rico. Where testing infrastructure is thin, many children with autism simply go uncounted.
Autism in Adults
Most prevalence data focuses on children, but autism is a lifelong condition. A 2017 estimate published through the CDC found that roughly 2.2% of U.S. adults aged 18 and older, about 5.4 million people, have autism spectrum disorder. State-level estimates ranged from about 2.0% in Louisiana to 2.4% in Massachusetts.
The adult figure is almost certainly an undercount. Many adults, particularly women and people of color, grew up before widespread screening existed and have never received a formal diagnosis. The gap between the childhood rate (3.2%) and the adult estimate (2.2%) likely reflects decades of under-identification rather than a true difference in how common autism is across generations.
The Economic Scale
Autism carries substantial costs for families and the broader economy. A CDC-published analysis forecast that the combined costs of medical care, non-medical services like behavioral therapy and special education, and lost productivity would reach $461 billion annually by 2025. That range could stretch as high as $1 trillion depending on assumptions about service use, representing up to 3.6% of U.S. GDP.
These figures underscore why early identification matters financially as well as developmentally. Children who receive support earlier tend to need fewer intensive services later, and adults who receive appropriate accommodations are more likely to participate in the workforce. The rising prevalence numbers make the case for investing in the screening and service infrastructure that states like California and Pennsylvania have already built.